ロード中...
The Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4(+) T Cells
Cellular immunotherapy is a proven approach against Epstein-Barr virus (EBV)-driven lymphoproliferation in recipients of hematopoietic stem cells. Extending the applicability and improving the response rates of such therapy demands improving the knowledge base. We studied 23 healthy donors for speci...
保存先:
| 出版年: | J Virol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7375367/ https://ncbi.nlm.nih.gov/pubmed/32461311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00284-20 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|